Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Cagrilintide Does Not Affect the Exposure of the Combined Oral Contraceptive Ethinyloestradiol/Levonorgestrel or Gastric Emptying as Measured by the Paracetamol Absorption Test
Authors:
Jennifer van der Horst1; Niels-Peter Becker1; Julie B. Hjerpsted2; Katrine Kirkeby1; Michal Tomasz Marzec1; Gaetano Morelli3; Louise Witten1